Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

While the BSE prices are correct on the website, the percentage change is not accurate.
We are in the process of rectifying the same.

Auto, energy stocks lead the gains
Thu, 15 Oct Closing

Buoyed by strong sentiments across Asia and Europe, Indian stock markets performed well today and ended well above the dotted line. While the BSE-Sensex closed higher by around 230 points, gains on the NSE-Nifty came in at around 72 points. S&P BSE Midcap and S&P BSE Smallcap indices also closed strong, edging higher by around 0.8% and 0.5% respectively. Auto and oil and gas stocks emerged as the top gainers.

Healthcare sector finished the day with modest gains with IPCA Labs and Opto Circuits leading the gains. According to a leading financial daily, Swiss pharmaceutical firm Helsinn Healthcare SA has settled patent litigations relating to its anti-nausea injection Aloxi with Dr. Reddy's Laboratories Ltd. The settlement will allow Dr. Reddy's to market the generic version of Aloxi in the US on 30 September 2018 or earlier under certain circumstances. Aloxi generically called as palonosetron HCl injection is used to treat chemotherapy-induced nausea and vomiting in patients suffering from cancer. Reportedly, Aloxi had sales of nearly US$416 million in the US and Canada for the year ended 31 March.

ValuePro recently wrote an article in the '5 Minute Wrap Up Premium' highlighting the issues faced by Dr Reddy's. The article gives an in depth view of the company's delay in product launch.

Tata Consultancy Services (TCS) is reportedly in talks with nine of the 11 payments bank license holders to offer operational solutions. The company has been a key participant for government deals in the domestic market. In the banking sector, it works with most of the leading lenders. State Bank of India, the largest public sector bank, has its core banking operations on TCS' banking platform, BaNCS.

Here is our analysis of the results.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Auto, energy stocks lead the gains". Click here!


Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Oct 23, 2017 11:29 AM